Catalyst Wire Dossier Catalyst Wire Dossier

Alpharadin

Radium-223 chloride · Bayer
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Alpharadin, covering 2014-06-25 to 2017-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases [Phase 3]

See pricing